Impaired leucocyte rolling, adhesion and transendothelial migration following cuprophane haemodialysis.
In this study, we investigated how different steps in the extravasation process of leucocytes, i.e. rolling, adhesion and transendothelial migration, are affected by haemodialysis with cuprophane membranes. Human leucocytes obtained from whole blood prior to clinical haemodialysis and from the afferent blood line (post-dialyser) 15 min after the initiation of dialysis were injected into the mesenteric microcirculation of urethane anaesthetized rabbits and analysed for their ability to roll in the microvessels by use of intravital fluorescence microscopy. Moreover, neutrophils from the two leucocyte populations were compared with respect to chemoattractant-induced adhesion and transmigration across confluent monolayers of bovine aortic endothelial cells. Our results show that, as compared with pre-dialysis leucocytes, 15 min of cuprophane haemodialysis impaired leucocyte rolling by 78 +/- 7%, reduced N-formyl-methionyl-leucyl-phenylalanin (fMLP)-induced adhesion by 34 +/- 9%, and abolished transendothelial migration. These findings demonstrate that intradialytical activation of leucocytes during cuprophane haemodialysis severely affects leucocyte functions that are critical in the extravasation process of these cells at inflammatory tissue sites, and thus may help explain the increased susceptibility to infections observed in patients on chronic haemodialysis.
Thorlacius
H
H
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Fernvik
E
E
Gautam
N
N
Lundahl
J
J
Raud
J
J
Jacobson
S H
SH
Lindbom
L
L
D000818:Animals; D001672:Biocompatible Materials; D002417:Cattle; D002448:Cell Adhesion / Q000502:physiology*; D002482:Cellulose / Q000031:analogs & derivatives*; D002634:Chemotaxis, Leukocyte / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000494:pharmacology; D007962:Leukocytes / Q000502:physiology*; D008567:Membranes, Artificial; D009504:Neutrophils / Q000502:physiology*; D011817:Rabbits; D006435:Renal Dialysis / Q000009:adverse effects*
D001672:Biocompatible Materials; D007375:Interleukin-1; D008567:Membranes, Artificial; D002482:Cellulose; C009865:cuprammonium cellulose